|
MORF4L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.96859997589638E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.36549998769931E-09 |
| Normal-vs-Stage2 |
2.10400000000277E-06 |
| Normal-vs-Stage3 |
1.08980000002035E-06 |
| Normal-vs-Stage4 |
3.976900E-04 |
| Stage1-vs-Stage2 |
7.317400E-01 |
| Stage1-vs-Stage3 |
9.420000E-01 |
| Stage1-vs-Stage4 |
8.307600E-01 |
| Stage2-vs-Stage3 |
7.673600E-01 |
| Stage2-vs-Stage4 |
9.708000E-01 |
| Stage3-vs-Stage4 |
8.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.53900003430874E-09 |
| Normal-vs-AfricanAmerican |
2.93950000007648E-07 |
| Normal-vs-Asian |
2.762300E-04 |
| Caucasian-vs-AfricanAmerican |
8.299800E-01 |
| Caucasian-vs-Asian |
4.052400E-01 |
| AfricanAmerican-vs-Asian |
2.814200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.24050003602605E-09 |
| Normal-vs-Female |
2.185600E-04 |
| Male-vs-Female |
8.976100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.34290000000748E-06 |
| Normal-vs-Extreme_Weight |
1.43520000328579E-08 |
| Normal-vs-Obese |
1.08649999996935E-06 |
| Normal-vs-Extreme_Obese |
2.17739999999189E-05 |
| Normal_Weight-vs-Extreme_Weight |
8.736200E-01 |
| Normal_Weight-vs-Obese |
6.020000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.745600E-01 |
| Extreme_Weight-vs-Obese |
4.418800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.397400E-01 |
| Obese-vs-Extreme_Obese |
3.085400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.91699999999773E-05 |
| Normal-vs-Age(41-60Yrs) |
9.74580000034919E-07 |
| Normal-vs-Age(61-80Yrs) |
6.1956995089929E-10 |
| Normal-vs-Age(81-100Yrs) |
2.16320000001602E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.547000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.177400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.600800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.660500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.561400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.78440000448066E-08 |
| Normal-VS-Type2 PRCC |
7.13659997764182E-09 |
| Normal-VS-KIRP CIMP |
5.753900E-04 |
| Normal-VS-Unclassified PRCC |
1.69772999999429E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.084300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.867200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.959000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.271200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.275200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.047800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.80109996203737E-09 |
| Normal-vs-N1 |
1.4569999999825E-06 |
| Normal-vs-N2 |
7.996500E-03 |
| N0-vs-N1 |
4.558400E-01 |
| N0-vs-N2 |
9.605000E-01 |
| N1-vs-N2 |
7.684400E-01 |
|
|
